Adenoviral Gene Transfer of Endothelin-1 in the Lung Induces Pulmonary Fibrosis through the Activation of Focal Adhesion Kinase
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Endothelin-1 (ET-1) has been implicated in the development of pulmonary fibrosis, based on its capacity in vitro to promote extracellular matrix (ECM) production and contraction, and on studies showing elevated expression of ET-1 and its receptors in patients with pulmonary fibrosis. However, the in vivo fibrogenic effect of ET-1 is not well characterized. We used the adenoviral-mediated gene transfer of ET-1 to overexpress ET-1 transiently in murine lungs by intratracheal administration. An increased expression of ET-1 for 3 to 10 days after injection resulted in a moderate but reversible fibrotic response, peaking on Day 14 after infection and characterized by the deposition of ECM components, myofibroblast formation, and a significant inflammatory infiltrate, mainly in the peribronchiolar/perivascular region. Adenoviral-mediated ET-1 overexpression activated focal adhesion kinase (FAK) both in vitro, using primary murine lung fibroblasts, and in vivo, intratracheally administered in the lungs of mice. The inhibition of FAK with the compound PF-562,271 prevented ET-1–mediated collagen deposition and myofibroblast formation, thereby preventing the development of lung fibrosis. In conclusion, we demonstrate that the overexpression of ET-1 directly in the lungs of mice can initiate a fibrogenic response characterized by increased ECM deposition and myofibroblast formation, and that this effect of ET-1 can be prevented by inhibition of FAK. Our data suggest that the ET-1/FAK axis may contribute importantly to the pathogenesis of fibrotic disorders, and highlight FAK as a potential therapeutic target in these devastating diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Myofibroblasts also secrete and/or activate various autocrine and paracrine mediators to facilitate wound healing.”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [14]
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
TGF-β signaling and the fibrotic response
Leask, A., & Abraham, D. J. (2004) · The FASEB Journal · doi:10.1096/fj.03-1273rev · Cited by 2,319
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
Wynn, T. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31487 · Cited by 1,456
Idiopathic Pulmonary Fibrosis: Clinical Relevance of Pathologic Classification
KATZENSTEIN, A.-L. A., & MYERS, J. L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9707039 · Cited by 1,261
Systemic sclerosis: a prototypic multisystem fibrotic disorder
Varga, J., & Abraham, D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31139 · Cited by 1,163
Sime, P. J., Xing, Z., Graham, F. L., Csaky, K. G., & Gauldie, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119590 · Cited by 1,050
Moeller, A., Ask, K., Warburton, D., Gauldie, J., & Kolb, M. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.08.011 · Cited by 1,007
Standardized Quantification of Pulmonary Fibrosis in Histological Samples
Hübner, R.-H., Gitter, W., Eddine El Mokhtari, N., Mathiak, M., Both, M., Bolte, H., Freitag-Wolf, S., & Bewig, B. (2008) · BioTechniques · doi:10.2144/000112729 · Cited by 817
Kolb, M., Margetts, P. J., Anthony, D. C., Pitossi, F., & Gauldie, J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12568 · Cited by 753
BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
King, T. E., Brown, K. K., Raghu, G., du Bois, R. M., Lynch, D. A., Martinez, F., Valeyre, D., Leconte, I., Morganti, A., Roux, S., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201011-1874oc · Cited by 718
Cited by
Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases
Hinz, B., & Lagares, D. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0324-5 · Cited by 614
Self-citationTargeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis
Lagares, D., Santos, A., Grasberger, P. E., Liu, F., Probst, C. K., Rahimi, R. A., Sakai, N., Kuehl, T., Ryan, J., Bhola, P., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal3765 · Cited by 246
Self-citationMatrix Stiffness: the Conductor of Organ Fibrosis
Santos, A., & Lagares, D. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0710-z · Cited by 177
Self-citationSisson, T. H., Ajayi, I. O., Subbotina, N., Dodi, A. E., Rodansky, E. S., Chibucos, L. N., Kim, K. K., Keshamouni, V. G., White, E. S., Zhou, Y., et al. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.12.005 · Cited by 158
Unraveling SSc Pathophysiology; The Myofibroblast
van Caam, A., Vonk, M., van den Hoogen, F., van Lent, P., & van der Kraan, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02452 · Cited by 153
“Furthermore, myofibroblasts produce endothelin 1, a potent vasoconstrictor but also a factor which stimulates the formation of new myofibroblasts (14) and enhances their function in regard to collagen production and contractile properties (15).”
BackgroundMechano-therapeutics: Targeting Mechanical Signaling in Fibrosis and Tumor Stroma
Tschumperlin, D. J., & Lagares, D. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107575 · Cited by 141
Self-citationMechanisms for the Resolution of Organ Fibrosis
Horowitz, J. C., & Thannickal, V. J. (2018) · Physiology · doi:10.1152/physiol.00033.2018 · Cited by 144
Planas‐Rigol, E., Terrades-García, N., Corbera‐Bellalta, M., Lozano, E., Alba, M. A., Segarra, M., Espígol‐Frigolé, G., Prieto‐González, S., Hernández‐Rodríguez, J., Preciado, S., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210792 · Cited by 96
The cytokines of pulmonary fibrosis: Much learned, much more to learn
Luzina, I. G., Todd, N. W., Sundararajan, S., & Atamas, S. P. (2014) · Cytokine · doi:10.1016/j.cyto.2014.11.008 · Cited by 100
Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis
Korman, B. D. (2019) · Translational research · doi:10.1016/j.trsl.2019.02.010 · Cited by 93
The profibrotic role of endothelin-1: Is the door still open for the treatment of fibrotic diseases?
Rodríguez-Pascual, F., Busnadiego, O., & González-Santamaría, J. (2014) · Life Sciences · doi:10.1016/j.lfs.2013.12.024 · Cited by 83
Self-citationZhang, J., Fan, G., Zhao, H., Wang, Z., Li, F., Zhang, P., Zhang, J., Wang, X., & Wang, W. (2017) · Scientific Reports · doi:10.1038/srep43146 · Cited by 68
A topographic atlas defines developmental origins of cell heterogeneity in the human embryonic lung
Sountoulidis, A., Salas, S. M., Braun, E., Avenel, C., Bergenstråhle, J., Theelke, J., Vicari, M., Czarnewski, P., Liontos, A., Abalo, X. M., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-022-01064-x · Cited by 79
Merkt, W., Zhou, Y., Han, H., & Lagares, D. (2021) · Wound Repair and Regeneration · doi:10.1111/wrr.12952 · Cited by 69
Self-citationLazarini, M., Traina, F., Machado‐Neto, J. A., Barcellos, K. S. A., Moreira, Y. B., Brandão, M. M., Verjovski‐Almeida, S., Ridley, A. J., & Saad, S. T. O. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.010 · Cited by 65
Long Noncoding RNA FENDRR Exhibits Antifibrotic Activity in Pulmonary Fibrosis
Huang, C., Liang, Y., Zeng, X., Yang, X., Xu, D., Gou, X., Sathiaseelan, R., Senavirathna, L. K., Wang, P., & Liu, L. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0293oc · Cited by 57
LDLR dysfunction induces LDL accumulation and promotes pulmonary fibrosis
Shi, X., Chen, Y., Liu, Q., Mei, X., Liu, J., Tang, Y., Luo, R., Sun, D., Ma, Y., Wu, W., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.711 · Cited by 44
PTEN improve renal fibrosis in vitro and in vivo through inhibiting FAK/AKT signaling pathway
Du, Y., Liu, P., Chen, Z., He, Y., Zhang, B., Dai, G., Xia, W., Liu, Y., & Chen, X. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29057 · Cited by 43
Modeling Pulmonary Disease Pathways Using Recombinant Adeno-Associated Virus 6.2
Strobel, B., Duechs, M. J., Schmid, R., Stierstorfer, B., Bucher, H., Quast, K., Stiller, D., Hildebrandt, T., Mennerich, D., Gantner, F., et al. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0338ma · Cited by 39
A story of fibers and stress: Matrix‐embedded signals for fibroblast activation in the skin
Sawant, M., Hinz, B., Schönborn, K., Zeinert, I., Eckes, B., Krieg, T., & Schuster, R. (2021) · Wound Repair and Regeneration · doi:10.1111/wrr.12950 · Cited by 39
Cutolo, M., Ruaro, B., Montagna, P., Brizzolara, R., Stratta, E., Trombetta, A. C., Scabini, S., Tavilla, P., Parodi, A., Corallo, C., et al. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1577-0 · Cited by 30
Rajshankar, D., Wang, B., Worndl, E., Menezes, S., Wang, Y., & McCulloch, C. A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29215 · Cited by 21
Zhou, Q., Chen, T., Bozkanat, K. M., Ibe, J. C. F., Christman, J. W., Raj, J. U., & Zhou, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0116142 · Cited by 21
Hua, H.-S., Wen, H.-C., Weng, C., Lee, H.-S., Chen, B.-C., & Lin, C. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00735-5 · Cited by 21
Endothelin‐1 mediates Aspergillus fumigatus‐induced airway inflammation and remodelling
Labram, B., Namvar, S., Hussell, T., & Herrick, S. E. (2019) · Clinical & Experimental Allergy · doi:10.1111/cea.13367 · Cited by 16
Gałdyszyńska, M., Zwoliński, R., Piera, L., Szymański, J., Jaszewski, R., & Drobnik, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114289 · Cited by 13
Bouloukaki, I., Michelakis, S., Tsitoura, E., Vasarmidi, E., Koutoulaki, C., Tzanakis, Ν., Schiza, S. E., & Antoniou, K. M. (2024) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2024.12766 · Cited by 6
Why Stress Matters: An Introduction
Tschumperlin, D. J. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1382-5_12 · Cited by 6
Outstaying their Welcome: The Persistent Myofibroblast in IPF.
Huang, S. K., & Horowitz, J. C. (2014) · PubMed · Cited by 10
Yu, X. H., Cao, J., Wang, B., Fu, J., Liu, J., Sui, T., Wang, Z., Wu, C., Chang, J., Cao, X., et al. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110398 · Cited by 4
Current and Future Strategies for the Diagnosis and Treatment of Cardiac Fibrosis
Roche, P. L., & Czubryt, M. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-17437-2_11 · Cited by 5
Zhu, Z., Li, M., Meng, Q., Chen, H., Tan, C., & Zhang, H. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152507 · Cited by 1
Fibroblast biology in idiopathic pulmonary fibrosis
Horowitz, J. C., & Thannickal, V. J. (2015) · doi:10.2217/fmeb2013.13.205 · Cited by 2
Cellular and Molecular Mechanisms of Fibrosis in Systemic Sclerosis
Trojanowska, M., Varga, J., & Lagares, D. (2024) · Springer eBooks · doi:10.1007/978-3-031-40658-4_18 · Cited by 2
Self-citationHorowitz, J. C. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0417ed · Cited by 1
BH3 Mimetic Drugs for Anti-fibrotic Therapy
Lagares, D. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781788015783-00235
Self-citationMechanotherapeutics for the Treatment of Idiopathic Pulmonary Fibrosis
Lagares, D., & Han, H. (2026) · Barcelona Respiratory Network · doi:10.23866/brnrev:2020-0012
Self-citationAbual’anaz, B. M., Rattan, S. G., & Dixon, I. (2023) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-14952-8_13
Effect of senescence on human mesenchymal stromal cells’ anti-fibrotic function
Morales, I. E. A. (2024) · eScholarship@McGill (McGill) · doi:10.82308/33863
Lee, H.-S., Lo, C., Hua, H.-S., Chen, B.-C., & Lin, C. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178719
Early to midgestational testosterone excess leads to adverse lung programming in sheep offspring
Razan, M. R., Woo, K. V., Purswani, D., Bernal, D., Alkhatib, B., Li, T., Padmanabhan, V., & Vyas, A. K. (2026) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00034.2026
Metadata
- Authors
- Lagares, D., Busnadiego, O., García-Fernández, R. A., Lamas, S., & Rodríguez-Pascual, F.
- Affiliations
- Consejo Superior de Investigaciones Científicas (ES)
- Centro de Biología Molecular Severo Ochoa and Laboratorio Mixto Consejo Superior de Investigaciones Científicas/Fundación Renal Iñigo Alvarez de Toledo, Universidad Autónoma de Madrid, Madrid, Spain; and
- Universidad Complutense de Madrid (ES)
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-12-01
- Volume
- 47
- Issue
- 6
- Pages
- 834-842
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- OpenAlex
- W2061385921
- Cited by
- 40
- References
- 49
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 5 · 2020: 2 · 2019: 6 · 2018: 4 · 2017: 4 · 2015: 4 · 2014: 4 · 2012: 1
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory Cell and Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Keywords
- endothelin-1, pulmonary fibrosis, focal adhesion kinase, adenoviral gene transfer, extracellular matrix deposition, myofibroblast differentiation, collagen deposition, lung fibroblasts, lung inflammation, therapeutic target
- MeSH terms
- Adenoviridae, Animals, B-Lymphocytes, Cell Differentiation, Cells, Cultured, Enzyme Activation, Genetic Vectors, Humans, Indoles, Lung, Mice, Inbred C57BL, Phosphorylation, Protein Processing, Post-Translational, Pulmonary Fibrosis, Recombinant Proteins, Scleroderma, Systemic, Sulfonamides, T-Lymphocytes, Endothelin-1, Mice, Focal Adhesion Protein-Tyrosine Kinases, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.